![]() ![]() Blood clots in the veins of the legs and lungs have happened more often in people who are 50 years and older and with at least 1 heart disease (CV) risk factor. This may be life-threatening and cause death. Blood clots in the veins of the legs or lungs and arteries can happen with RINVOQ. Increased risk of major cardiovascular (CV) events, such as heart attack, stroke, or death, in people 50 years and older who have at least 1 heart disease (CV) risk factor, especially if you are a current or past smoker.Wear protective clothing when you are in the sun and use sunscreen. Limit the amount of time you spend in sunlight. Follow your HCP's advice about having your skin checked for skin cancer during treatment with RINVOQ. Current or past smokers are at higher risk of certain cancers, including lymphoma and lung cancer. Lymphoma and other cancers, including skin cancers, can happen. RINVOQ may increase your risk of certain cancers. Increased risk of death in people 50 years and older who have at least 1 heart disease (cardiovascular) risk factor.You may be at higher risk of developing shingles (herpes zoster). If you get a serious infection, your HCP may stop your treatment until your infection is controlled. You should not start taking RINVOQ if you have any kind of infection unless your HCP tells you it is okay. Your healthcare provider (HCP) should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ. Some people have died from these infections. Serious infections have happened while taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. RINVOQ can lower your ability to fight infections. RINVOQ may cause serious side effects, including: What is the most important information I should know about RINVOQ? It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis. RINVOQ is safe and effective in children 12 years of age and older weighing at least 88 pounds (40 kg) with atopic dermatitis. Adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis ) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended.It is not known if RINVOQ is safe and effective in children with juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative colitis, or Crohn’s disease. Adults with moderate to severe Crohn’s disease (CD) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.Adults with moderate to severe ulcerative colitis (UC) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.Adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation when a TNF blocker medicine has been used, and did not work well or could not be tolerated.Adults with active ankylosing spondylitis (AS) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.Adults with active psoriatic arthritis (PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.Adults with moderate to severe rheumatoid arthritis (RA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated. ![]() RINVOQ is a prescription medicine used to treat: ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |